Jovicić A, Raicević R, Bosković B
Vojnosanit Pregl. 1998 May-Jun;55(3):265-9.
Headache, as a syndrome, represents large health and wider socio-economic problem in every community for its massive occurrence and frequent absence of therapeutic response to the administered analgesics. That is why the finding, and later production of the drug that would satisfy the criteria of analgesic, efficacious in the treatment of headache, without the entering in etiology of syndrome are presented as the imperative. In connection with that was set the aim of the investigation: to investigate comparative analgesic efficacity of new preparation--Dikalm compared to analgesic that was for a long time present in our pharmaceutic market--Saridon tablets in the patients with different neurologic diseases, where headache represents the leading symptom of their difficulties. The investigation included 30 patients--10 patients were cross-examined with the use of both preparations in the treatment of headache episodes that appeared in separate time interval, and 20 patients received one another preparation. The headache intensity, residual headache, adverse effects and the need for repeating were graded by original standardized scales. The results of investigation revealed significantly better analgesic effect of therapeutic combination contained in Dikalm preparation, as for persistent, residual headache, as for the need of repeating the analgesics administration, what was specially pronounced in the group that cross-received both preparations, or in the whole group compared to the therapeutic combination contained in Saridon tablets. It was concluded that Dikalm represented the drug with efficacious analgesic and with minimal adverse effects.
头痛作为一种综合征,因其大量发生且对所使用的镇痛药常常缺乏治疗反应,在每个社区都构成了重大的健康问题和更广泛的社会经济问题。这就是为什么寻找并随后生产出一种符合镇痛药标准、对治疗头痛有效的药物,且不涉及综合征病因,被视为当务之急。与此相关,确定了本研究的目的:在以头痛为主要症状的不同神经系统疾病患者中,研究新制剂——迪卡尔姆(Dikalm)与长期在我们药品市场上销售的镇痛药——散利痛片相比的镇痛效果。该研究纳入了30名患者——10名患者在不同时间间隔出现头痛发作时,交叉使用这两种制剂进行治疗,另外20名患者分别接受其中一种制剂治疗。通过原始的标准化量表对头痛强度、残余头痛、不良反应和重复用药需求进行分级。研究结果显示,迪卡尔姆制剂中的治疗组合在持续头痛、残余头痛以及重复使用镇痛药的需求方面,镇痛效果显著优于散利痛片中的治疗组合,这在交叉使用两种制剂的组中或与整个组相比时尤为明显。得出的结论是,迪卡尔姆是一种具有有效镇痛作用且不良反应最小的药物。